HIV drug shortages hit aid groups in over half of surveyed nations
A survey by the International Planned Parenthood Federation found that more than half of its member organizations reported running out of HIV medicines and tests within the past year.
Survey results show widespread stockouts
The International Planned Parenthood Federation surveyed 40 countries regarding supply levels for essential health products. More than 55% of responding organizations stated they had completely run out of key medicines or tests in the last twelve months. Additionally, 60% of members reported having at least one product at low stock levels.
Diagnostic tests face critical gaps
Findings indicate that HIV rapid diagnostic tests are the most critically affected product across all respondents. A significant scarcity exists specifically for pre-exposure prophylaxis, which is a prescription medicine used to reduce infection risk. At the time of questioning, 40% of members reported having run out of all stock for specific products.
Funding cuts threaten progress
Experts warn that uncertain funding makes supply systems fragile and risks undoing decades of progress against HIV. Infections are rising in several countries while lives are being lost due to unavailable treatments. Aid cuts have directly affected drug and test supplies across the world according to the data.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.